Sandoz Inc Drug Patent Portfolio

Sandoz Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sandoz Inc News

Forecast for the Generic Oncology Drug Market by 2031: Trends and Growth Insights - openPR.com

14 Apr, 2026

Projection for the Generic Oncology Medications Market by 2031 - Developments and Trends

14 Apr, 2026

Novartis AG shares (CH0012005267): Does its pipeline of innovative medications have the potential to drive new growth?

14 Apr, 2026

Generics accuse GSK of engaging in a "divisional strategy" following the revocation of EPO - JUVE Patent

12 Mar, 2026

See More